Previous Article | Next Article 
Molecular and Cellular Biology, July 2001, p. 4737-4747, Vol. 21, No. 14
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.14.4737-4747.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Postrepression Activation of NF-
B Requires the
Amino-Terminal Nuclear Export Signal Specific to I
B
Tony T.
Huang and
Shigeki
Miyamoto*
Program in Molecular and Cellular
Pharmacology, Department of Pharmacology, University of
Wisconsin
Madison, Madison, Wisconsin 53706-1532
Received 31 January 2001/Accepted 24 April 2001
 |
ABSTRACT |
One of the most prominent NF-
B target genes in mammalian cells
is the gene encoding one of its inhibitor proteins, I
B
. The
increased synthesis of I
B
leads to postinduction repression of
nuclear NF-
B activity. However, it is unknown why I
B
, among multiple I
B family members, is involved in this process and what significance this feedback regulation has beyond terminating NF-
B activity. Herein, we report an important I
B
-specific function dictated by its amino-terminal nuclear export sequence (N-NES). The
I
B
N-NES is necessary for the postinduction export of nuclear NF-
B, which is a critical event in reestablishing a permissive condition for NF-
B to be rapidly reactivated. We show that although I
B
and another I
B member, I
B
, can enter the nucleus and
repress NF-
B DNA-binding activity during the postinduction phase,
only I
B
allows the efficient export of nuclear NF-
B. Moreover,
swapping the N-terminal region of I
B
for the corresponding
I
B
sequence is sufficient for the I
B chimera protein to export
NF-
B similarly to I
B
during the postinduction state. Our
findings provide a mechanistic explanation of why I
B
but not
other I
B members is crucial for postrepression activation of
NF-
B. We propose that this I
B
-specific function is important
for certain physiological and pathological conditions where NF-
B
needs to be rapidly reactivated.
 |
INTRODUCTION |
The NF-
B/Rel family of inducible
transcription factors is involved in the expression of numerous genes
involved in important cellular and physiological processes such as
growth, development, apoptosis, and inflammatory and immune responses
(15, 45). Members of the Rel family include p65 (RelA),
p105/p50, p100/p52, RelB, and c-Rel. These transcription factors can
form homo- or heterodimers with each other to make transcriptionally
competent or repressive complexes, loosely referred to as the nuclear
factor kappa B (NF-
B). The biological activity of NF-
B is tightly
regulated by its inhibitor protein, I
B. Members of the I
B family
include I
B
, I
B
, I
B
, Bcl-3, and the best-characterized
member, I
B
(15). In most cells, I
B
and
I
B
are found associated with the p50-p65 heterodimer, the most
ubiquitous NF-
B, to form a stable trimeric complex inside the cell.
The subcellular localization of NF-
B-I
B complexes dictates the
ability of NF-
B to be activated by extracellular stimuli such as
tumor necrosis factor alpha (TNF-
). We and others have previously
shown that cytoplasmic localization of preinduced NF-
B-I
B complexes is important for efficient cytokine-dependent
phosphorylation-ubiquitination and subsequent degradation of I
B
proteins, which cause the release of NF-
B to the nucleus to alter
gene expression (17, 38). Nuclear NF-
B-I
B
complexes, however, are generally refractory to cytokine-induced I
B
degradation. These observations suggest that cytoplasmic localization
of NF-
B-I
B complexes plays an important role during the pre- and
postinduced stages of NF-
B activation.
Localization of preinduced NF-
B population is partly controlled by
an N-terminal nuclear export signal (N-NES) on I
B
(17, 23,
38, 43). NF-
B complexes formed with I
B
have a tendency to shuttle rapidly between the cytoplasm and nucleus, likely due to
leaky exposure of p50 nuclear localization signal (NLS) coupled to a
more dominant nuclear export by I
B
(17, 22).
However, it is unknown whether I
B
or other I
B members bound to
NF-
B can also shuttle nucleocytoplasmically in the absence of stimuli.
The localization of postinduced nuclear NF-
B population is also
carefully controlled, presumably by I
B
(1, 47).
Postinduction repression refers to the condition in which activated
nuclear NF-
B upregulates the expression of I
B
due to NF-
B
consensus binding sites within the I
B
promoter (7, 8, 21,
27, 42), followed by nuclear accumulation of free I
B
,
which dissociates NF-
B from NF-
B-bound DNA complexes to repress
NF-
B function (2). These newly formed nuclear
NF-
B-I
B
complexes are then exported out to the cytoplasm,
thereby reestablishing the cytoplasmic pool of inactive NF-
B
complexes that are primed for another round of activation to take place
(2). Recent reports have shown intrinsic nuclear export
functions in both I
B
(2, 17, 23, 38, 39, 43) and the
p65 subunit of NF-
B complexes (16). However, it remains
to be determined which of these newly characterized NESs can facilitate
postinduction export of nuclear NF-
B complexes.
The leucine-rich NES motif is an evolutionarily conserved sequence used
by a variety of proteins to facilitate their delivery from the nucleus
to the cytoplasm and is also used as an important point of control by
the cell to regulate protein function through subcellular localization
(24, 28). Leptomycin B (LMB) is an extremely useful tool
used to selectively inhibit Crm1 (exportin-1)-dependent nuclear export
of NES-containing proteins (10, 11, 26, 35, 41). LMB
appears to covalently modify Crm1 export receptor at a conserved
cysteine residue that renders the receptor incapable of forming the
exporting trimeric complex between cargo protein and RanGTP
(25).
In the present study, we provide evidence that I
B
may be the only
NF-
B inhibitor protein to possess an intrinsic nuclear export
function. We employed LMB, knockout cells, chimeric constructs, and
transient and stable transfection studies to monitor subcellular localization of NF-
B-I
B complexes, degradation of I
B
proteins, and NF-
B DNA-binding activities during pre-and
postinduction states. We found that N-NES of I
B
is primarily
responsible for export of NF-
B during pre- and postinduction states.
However, NF-
B-I
B
complexes are incapable of shuttling during
both of these states, suggesting that, unlike I
B
, I
B
is
capable of completely masking nuclear localization sequences of the
NF-
B dimer and incapable of exporting the complex out of the
nucleus. Swapping the N-terminal region of I
B
for I
B
sequence allows NF-
B bound to the chimeric protein to be exported
out of the nucleus in a manner identical to I
B
. These results
provide deeper insights into the fundamental differences between
regulatory mechanisms governing function of I
B
and I
B
and
possibly other I
B members and implicate biological relevance
of I
B
-specific nuclear export function in regulation of such
processes as apoptosis and inflammatory responses.
 |
MATERIALS AND METHODS |
Cell culture.
Mouse embryo fibroblasts (MEFs), 293 human
embryonic kidney cells (HEK), and Cos-7 cells were maintained in
Dulbecco's modified Eagle's medium (DMEM) (Cellgro) supplemented with
10% fetal bovine serum (HyClone Laboratory, Inc.), 1,000 U of
penicillin G (Sigma Chem. Co., St. Louis, Mo.), and 0.5 mg of
streptomycin sulfate (Sigma) per ml in a humidified 10%
CO2 incubator (Forma Scientific). The p65
/
3T3 cells were maintained in DMEM with 10% bovine calf serum and
supplemented with antibiotics as above. Cells (embryonic fibroblasts and Cos-7) were transiently transfected using the Effectene
transfection reagent (Qiagen) and the standard calcium phosphate
precipitation method (5).
Reagents.
Dimethyl sulfoxide (DMSO) and cycloheximide were
purchased from Sigma. MG132 was purchased from Peptides International.
Human recombinant TNF-
was from CalBiochem and resuspended in
phosphate-buffered saline (PBS) containing 0.1% bovine serum albumin
(fraction V; Sigma). In each experiment, all samples received the same
amounts of DMSO to control for potential DMSO effects. Immunoglobulin G
(IgG) antibodies against I
B
(C21), I
B
(C20), and p65 (C20) were purchased from Santa Cruz Biotechnology. The 5432 rabbit polyclonal antibody was raised against the N-terminal 56 amino acids of
murine I
B
conjugated to glutathione S-transferase as described previously (30). A monoclonal anti-HA.11
(influenza virus hemagglutinin epitope) antibody was purchased from
BabCO, and horseradish peroxidase-conjugated anti-rabbit and anti-mouse Ig antibodies were obtained from Amersham. Fluorescein isothiocyanate (FITC)- and tetramethyl rhodamine isocyanate (TRITC)-conjugated anti-rabbit and anti-mouse Ig antibodies were purchased from Sigma. Hoechst dye 33342 and rhodamine phalloidin (R-415) were purchased from
Molecular Probes.
Western blot and EMSA procedures.
Cell preparation and
Western immunoblots were performed as described (31) and
developed using the enhanced chemiluminescent (ECL) procedure according
to the manufacturer (Amersham). Blots were then exposed to X-ray film
(Kodak). The Ig
-
B oligonucleotide probe and conditions for
electrophoretic mobility shift assay (EMSA) were previously described
(31). The total cell extract buffer (20 mM HEPES [pH
7.9], 350 mM NaCl, 20% glycerol, 1% NP-40, 1 mM MgCl2,
0.5 mM EDTA, 0.1 mM EGTA, 0.5 mM dithiothreitol, phenylmethylsulfonyl fluoride, and aprotinin) was used for both Western blot analysis and
EMSA. Nuclear and cytoplasmic biochemical fractionations were accomplished using buffer C and buffer A, respectively, as described (31).
Construction of I
B
, I
B
and p65 chimeras and fusion
proteins.
N-terminally fused green fluorescent protein
(GFP)-I
B
was generated by subcloning PCR-amplified human
wild-type I
B
(MAD3) into the HindIII and
BamHI sites of the pEGFP vector (Clontech). The human p65
cDNA was kindly provided by D. Ballard (Vanderbilt, Tenn.). To make the
GFP N-terminally tagged p65 fusion protein, the p65 cDNA with
HindIII and BamHI flanking sites was created by PCR and ligated in-frame into the pEGFP vector (Clontech). Truncated
p65s (amino acids [aa] 1 to 420 and 1 to 450) were made with 3'
primers specific to the C-terminal truncated portion of p65 and
subcloned into the pEGFP vector as above. The murine p65 cDNA was
blunt-end ligated into BamHI-NheI Klenow
blunt-ended pCMX vector (provided by K. Umesono, Kyoto University).
Similarly, CMX-p50 was generated by cleaving murine p105 cDNA at
NcoI sites, Klenow filled, and blunt-ligated into
BamHI-NheI Klenow blunt-ended pCMX vector.
I
B
expression vector was constructed by inserting murine I
B
cDNA into pcDNA vector (Clontech). The amount of each plasmid vector
was titrated to ensure the formation of I
B
and NF-
B complexes
in Cos-7 cells and MEFs. The I
B

construct (pLHL-CA-I
B

) was made by using specific primer sets with
either 3' I
B
or 5' I
B
overhangs to PCR amplify pBS-I
B
(1 to 66) and pBS-I
B
(45 to 359). The
two PCR products were joined by PCR using 5' I
B
and 3'
I
B
-specific primers, subcloned into pBS at 5' BamHI
and 3' XhoI, and subcloned into pLHL-CA vector at 5'
BamHI-BglII and 3' XhoI sites. The
N-NES mutant I
B

construct was constructed similarly to the
I
B

construct except that the pBS-I
B
N-NES mutant
construct was used as a template. The pBS-I
B
N-NES mutant
template was generated using two-step PCR mutagenesis as described
(17). The hemagglutinin (HA)-tagged murine I
B
gene
(pLHL-CAHA-mI
B
) was constructed as described previously
(31).
Visual analysis of NF-
B and I
B
proteins.
MEFs and
Cos-7 cell lines were cultured in two-or four-welled chamber slides
(Lab-Tek) and transiently transfected with various expression plasmid
constructs. After drug treatment, cells were washed twice with ice-cold
PBS and fixed with 3.7% formaldehyde in PBS for several hours at
4°C. Fixed cells were then rinsed with PBS and permeabilized with
0.2% Triton X-100 in PBS. Cells were blocked with 2% normal goat
serum for 1 h and subsequently incubated with appropriate primary
antibodies in PBS-0.2% Tween 20-2% goat serum at 37°C overnight.
Staining was detected with either FITC- or TRITC-conjugated anti-mouse
or -rabbit Ig secondary antibodies. Cells were mounted with Prolong
Antifade (Molecular Probes) and visualized and photographed using a
Zeiss Axioplan epifluorescence microscope with the aid of fluorescein-
or rhodamine-specific filters. GFP fusion protein was visualized
directly in living cells or under fixed conditions.
Generation of stable pools of MEFs.
MEFs deficient for
I
B
were reconstituted with either HA-tagged murine I
B
or
the chimeric I
B

gene via retroviral infection as described
previously (31). Briefly, pLHL-CAHA-mI
B
or
pLHL-CA-I
B

and pLHL-CA-I
B

N-NESmut constructs
were contransfected with pCLeco (32) helper virus in HEK
293 cells. Viruses were then harvested and transferred onto MEFs for
infection. Stably infected pools of MEFs were selected in the presence
of hygromycin. The stable pools of MEFs were then grown in the absence
of hygromycin for 2 days before experiments were initiated.
 |
RESULTS |
LMB cannot inhibit activation of NF-
B associated with
I
B
.
It is known that nuclear export of NF-
B can be
mediated by the I
B
protein. It is yet unclear whether the
capacity to export NF-
B out of the nucleus is a general function of
all I
B family members. Scanning the primary amino acid sequences of
other I
B members, such as I
B
(44), p105/I
B
(14, 20, 37), p100 (29, 33), I
B
(46), and Bcl-3 (34), or cactus
(13), the Drosophila homolog of I
B, revealed
no conserved NES motifs N-terminal of the first ankyrin repeat compared
to I
B
(Fig. 1A; others not shown).
Since I
B
is widely expressed and responds to stimulus-dependent
degradation in a manner similar to I
B
, we chose to compare and
contrast the mechanistic differences in the ability of I
B
and
I
B
to modulate NF-
B localization and activation. Consistent
with earlier reports (17, 38), TNF-
-induced NF-
B
DNA-binding activity was inhibited by LMB (Fig. 1B, lower panel, lanes
2 and 3). However, surprisingly, LMB had no observable effect against
TNF-
-induced NF-
B activation in I
B
knockout cells (Fig. 1B,
lower panel, lanes 6 and 7). Although TNF-
induced the degradation
of both I
B
and I
B
in the wild-type cells, LMB selectively
retarded the degradation of I
B
, not I
B
(Fig. 1B, upper
panel, lanes 2 and 3). Likewise, I
B
was degraded by TNF-
stimulation but was not inhibited upon pretreatment with LMB in the
I
B
-deficient cells (Fig. 1B, upper panel, lanes 6 and 7). These
results show that LMB inhibits NF-
B activation only through the
I
B
protein. Together with a recent finding of the presence of a
functional NES on p65 but not on the p50 or c-Rel subunit of NF-
B
(16), our data suggest that the p65 NES does not
dominantly affect I
B
subcellular localization in an LMB-sensitive
fashion. Alternatively, unlike I
B
, I
B
completely masks both
nuclear localization sequences present on dimeric NF-
B complexes,
thereby preventing import of NF-
B in the uninduced state. In the
latter case, NF-
B-I
B
complexes do not shuttle in an
NES-dependent manner, making their subcellular localization LMB
insensitive.

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 1.
I B is refractory to LMB inhibition of
TNF- -induced degradation. (A) N-terminal primary amino acid sequence
alignment of I B and I B . Boxed region signifies the highly
conserved I B kinase phosphorylation sites on the dual serines on
I B and I B . Highlighted sequences (shaded box) are the
recently identified "leucine-rich" N-terminal NES of I B that
is not conserved in other I B proteins such as I B , I B ,
and cactus. (B) Wild-type and I B -deficient MEFs were untreated or
treated with TNF- (10 ng/ml for 15 min; lanes 2 to 4 and 6 to 8) in
the presence or absence of LMB (20 ng/ml; lanes 3 and 7) or MG132 (30 µM; lanes 4 and 8) pretreatment for 30 min. Total cell extracts were
analyzed by EMSA by using an Ig - B probe (lower panel) and by
Western blotting with I B (C-21) and I B (C-20) antibodies
(upper panel). (C) p65-deficient 3T3 cells were treated with TNF-
(10 ng/ml for 15 min; lanes 2 to 5) and pretreated in the presence or
absence of LMB (20 ng/ml) for 15, 30, or 60 min (lanes 3, 4, and 5, respectively). Total cell extracts were analyzed by EMSA as described
above (lower panel) and by Western blotting with I B - and
I B -specific antibodies (upper panel).
|
|
However, in the case of NF-

B associated with I

B

, it is unclear
which of the NES motifs present on p65 and I

B

plays a
dominant
role in the shuttling of NF-

B-I

B

complexes during
the
preinduced state. Using p65-deficient cells, we sought to
determine
whether NF-

B-I

B

complexes are sensitive to LMB-induced
nuclear localization in the absence of the p65 subunit. As in
wild-type
cells, TNF-

still targeted the degradation of both
I

B

and
I

B

and induced the appearance of NF-

B (primarily p50
and c-Rel
[
4]) binding activity in p65 knockout cells (Fig.
1C,
lower panel, lanes 1 and 2). As in wild-type cells, LMB still
inhibited
the degradation of I

B

(Fig.
1C, upper panel, lanes
3 to 5).
Coupled with our earlier observation that disruption
of I

B

N-NES
sequence causes nuclear accumulation of associated
NF-

B complexes
(
17), our results demonstrate that I

B

is the
primary
target of LMB action. These observations together demonstrate
that
during the preinduced state, the NF-

B-I

B

complexes still
shuttle between the cytoplasm and the nucleus even in the absence
of
the p65
NES.
I
B
is insensitive to LMB-induced nuclear accumulation in
preinduction state.
The above data suggest that NF-
B-I
B
complexes do not shuttle in an LMB-sensitive fashion, unlike those
containing I
B
. To directly determine whether the subcellular
localization of preinduced I
B
is not affected by LMB, endogenous
I
B
was stained with I
B
-specific antibodies and visualized
under a fluorescent microscope. As an internal control, I
B
subcellular localization was similarly monitored. In untreated MEFs,
both I
B
and I
B
were localized predominantly in the
cytoplasm (Fig. 2A, upper left panels).
Upon treatment of the cells with LMB, I
B
accumulated in the
nucleus, as expected (Fig. 2A, upper right panels). In contrast, the
localization of I
B
remained cytoplasmic. To ensure that selective
nuclear accumulation of I
B
but not I
B
was achieved upon LMB
treatment within the same cell, Cos cells were cotransfected with
HA-tagged I
B
, I
B
, and p50-p65 NF-
B subunits. Transfected cells were costained with antibodies specific to HA or I
B
, and localizations of I
B
and I
B
proteins were determined within the same cell. Exogenous I
B
was sensitive to LMB-induced nuclear accumulation, while I
B
did not migrate substantially into the nucleus (Fig. 2B, upper and middle panels). These results demonstrate that cytoplasmic localization of inactive NF-
B is controlled by at
least two different mechanisms. When NF-
B is complexed with
I
B
, the mechanism of localization is determined by the kinetics
of nucleocytoplasmic shuttling, with nuclear export being dominant
during the preinduced state. However, cytoplasmic localization of
NF-
B-I
B
is not regulated by an LMB-sensitive export
mechanism.

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 2.
NF- B-I B complexes do not shuttle between
cytoplasm and nucleus in an LMB-sensitive manner. (A) Wild-type MEFs
were untreated or treated with LMB (20 ng/ml for 30 min), fixed, and
stained with either I B (C-20) or I B (C-21) antibodies.
Cells were also costained with rhodamine-conjugated phalloidin to
visualize actin for cell cytoskeleton integrity. For control, cells
were also treated with LMB or TNF- as above and localization of p65
(C-20) was assessed. (B) Cos-7 cells were cotransfected with HA-tagged
I B (1.0 µg), I B (1.0 µg), p50 (1.0 µg), and p65 (1.0 µg) constructs, untreated or treated with LMB as described for panel
A, and stained with HA (red) and I B (green) antibodies. Cells
were also stained with Hoechst DNA dye (blue).
|
|
NF-
B cannot be sequentially activated without I
B
.
It
was recently shown that when the I
B
gene was replaced into the
I
B
locus under control of the I
B
promoter, it could repress
nuclear NF-
B DNA-binding activity following pulse induction with
TNF-
(6). Thus, it was concluded that I
B
is
functionally equivalent to I
B
. However, we hypothesize that the
export of NF-
B following the repression of NF-
B DNA-binding
activity allows the system to become permissive for reactivation or
postrepression activation of NF-
B. If NF-
B-I
B complexes are
nuclear, reactivation by a second round of stimulation would not occur,
since the activation event takes place primarily in the cytoplasmic
compartment. To directly test this hypothesis, we first established the
condition in which postinduction repression of NF-
B DNA-binding
activity can be reproducibly detected using both wild-type and
I
B
-deficient MEFs (Fig. 3). As
expected, resynthesis of I
B
directly correlated with the
reduction of NF-
B DNA-binding activity in wild-type cells (Fig. 3A
and B, lanes 3 to 6). Similarly, NF-
B DNA-binding activity
decreased, in good agreement with increased I
B
protein levels in
I
B
-deficient cells, but this effect required longer durations due
to the lack of NF-
B-dependent transcription of the I
B
gene
(Fig. 3A and B, lanes 6 and 14). Once these conditions were
established, MEFs were pulse stimulated with TNF-
and then chased
with medium without TNF-
for 2 h before reactivation studies were performed (diagram in Fig. 4). Secondary stimulation of these cells with TNF-
reactivated NF-
B DNA-binding activity in
wild-type cells (Fig. 4A, compare lanes 3 and 4). Importantly, while degradation of I
B
was observed during
the reactivation phase, I
B
was mostly refractory to this process
(Fig. 4A and B, lower panels, lanes 4). Consistent with the above
observation and also with our hypothesis, TNF-
could not efficiently
activate NF-
B for the second time in the absence of I
B
(Fig.
4B, lower panel, lanes 2 to 4). These results for the first time
demonstrate that the postrepression activation of NF-
B requires the
NF-
B-dependent resynthesis of I
B
, which cannot be compensated
for by other I
B family members.

View larger version (43K):
[in this window]
[in a new window]
|
FIG. 3.
Kinetic analyses of postinduction repression of NF- B
DNA-binding activity in the presence and absence of I B protein.
(A) Wild-type and I B -deficient MEFs were pulse treated for 10 min
with TNF- (10 ng/ml; lanes 2 to 6 and 8 to 14) and subsequently
chased with fresh medium without TNF- for the indicated amounts of
time (0, 15, 30, 45, 60, 90, and 120 min). Lanes 1 and 7, untreated
control samples. Total cell extracts from the samples were analyzed by
Western blotting using I B - and I B -specific antibodies (A)
and EMSA as described above (B).
|
|

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 4.
NF- B cannot be sequentially activated in the absence
of I B . (A) Wild-type MEFs were treated with TNF- (10 ng/ml for
10 min; lanes 2 to 4), then chased with fresh medium for 120 min (lanes
3 and 4), and finally restimulated with TNF- as above for 10 min
(lane 4). Total cell extracts were analyzed by both EMSA (upper panel)
and Western blotting (lower panel). The experimental setup is
diagrammed above. Numbers in parentheses signify the lanes of the
sample that were treated. (B) I B -deficient MEFs were treated as
described above. I B - and I B -specific antibodies were used
in both A and B.
|
|
Postinduction export of nuclear NF-
B is inefficient in the
absence of I
B
.
Our EMSA analyses indicate that postinduction
export of inactive NF-
B complexes out of the nucleus requires the
presence of I
B
. To directly determine the localization of
NF-
B-I
B complexes during the postinduction phase, we examined
the localization of the endogenous p65 by immunofluorescence in
wild-type and I
B
/
MEFs. The outline of the
postinduction export experiment is diagrammed in Fig.
5. Consistent with NF-
B-dependent
synthesis of I
B
within 30 to 60 min post-TNF-
stimulation
(Fig. 3), nuclear p65 in the wild-type cells was efficiently exported
out to the cytoplasm within 60 min of chase without TNF-
(Fig. 5,
panels C and D). Inclusion of cycloheximide or LMB during the chase
period blocked the export of p65 (Fig. 5, panels G and H),
demonstrating that nuclear export of NF-
B during the postinduction
phase indeed requires I
B
resynthesis and an NES-dependent
process. However, in the I
B
-deficient MEFs, the majority of p65
remained in the nucleus after 60 min during the chase period (Fig. 5,
panel K). Even after 3 h of chase, a large pool of p65 was nuclear
(panels L and M), correlating with the resistance of NF-
B to
reactivation by TNF-
(Fig. 4). Interestingly, adding LMB during the
chase period caused a further increase in the amount of p65 in the
nucleus (panel O). This observation suggests that an NES-dependent
process was responsible for some p65 export during the prolonged chase period in I
B
-deficient cells. These observations together
demonstrate that while efficient and rapid export of NF-
B during
postinduction phase requires the resynthesis of I
B
, it can be
exported less effectively in the absence of I
B
, possibly via the
recently identified NES on the p65 subunit.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 5.
Postinduction export of NF- B is sensitive to LMB and
inefficient in the absence of I B . Wild-type and
I B -deficient MEFs were treated with TNF- (10 ng/ml for 10 min;
panels B to H and J to O) and chased with fresh medium for the
indicated amounts of time (60, 120, or 180 min) in the presence or
absence of cycloheximide (CX; 10 µg/ml) or LMB (20 ng/ml). The
experimental setup is diagrammed above. The treated cells were then
fixed and the endogenous p65 was stained with p65 (C-20)-specific
antibody.
|
|
I
B
can enter the nucleus but is not efficiently exported
during postinduction phase.
The observations thus far suggest that
NF-
B associated with I
B
is exported efficiently but NF-
B
associated with I
B
is not during the postinduction phase. Direct
examination of subcellular localization of I
B
during
postinduction phase by both immunofluorescence and biochemical
subfractionation analyses confirmed that indeed newly synthesized
I
B
can enter the nucleus (Fig. 6A,
vector only, panel 3, and 6B, compare
I
B
, lane 7). Interestingly, the signal detected by C20
anti-I
B
antibody in immunofluorescence showed a similar extent of
degradation as with I
B
after 30 min of TNF-
stimulation (Fig.
6A, compare panels 2), but Western blot analyses consistently showed
incomplete I
B
degradation compared to I
B
within the same
time frame (Fig. 6B, I
B
and I
B
, lanes 2). The significance
of this observation is discussed below (see Discussion). Importantly,
while the presence of nuclear I
B
correlated well with the
repression of NF-
B DNA-binding activity in I
B
-deficient cells,
I
B
was not exported out of the nucleus even up to 3 h during
the chase period. LMB showed very little effect during the chase period
(Fig. 6A, panel 4), suggesting that subcellular localization of
I
B
is not affected by an NES-dependent export process. The lack
of nuclear export of I
B
was not due to some defect of the
I
B
-deficient cell system used because when I
B
tagged with
the HA epitope (HA-I
B
) was stably expressed, HA-I
B
was
efficiently exported during the postinduction phase in an LMB-sensitive
fashion in a manner identical to endogenous I
B
in wild-type cells
(Fig. 6A, HA-I
B
, panels 3 and 4). These results demonstrate that
while newly synthesized I
B
can enter the nucleus, it fails to
export efficiently out of the nucleus during the postinduction phase.

View larger version (48K):
[in this window]
[in a new window]
|
FIG. 6.
N-terminal region containing the N-NES of I B
is sufficient to mediate the postinduction export function.
(A) I B -deficient MEFs were stably transfected with
either vector (vector only), HA-tagged I B (HA-I B ),
I B  chimera (I B  ), or N-terminal NES mutant
I B  chimera contructs (I B  N-NESmut). Pools of
stable transfectants were isolated, and subcellular localization of
I Bs was visualized using antibodies against I B (C-20, vector
only), I B (C-21, HA-I B ), N-terminal 56 amino acids of
I B (5432, I B  , and I B   N-NESmut). The
cells were also treated with TNF- for 60 min (panels 2 to 4), chased
with fresh medium for 180 min (panels 3), or in the presence of LMB
(panels 4). (B) Stably transfected MEFs as above were either
untreated (lanes 1 and 5), pulsed with TNF- for 30 min (lanes 2 and
6), chased with fresh growth medium for 120 min (lanes 3 and 7), and
rechallenged with TNF- for another 30 min (lanes 4 and 8). Samples
from each pool of cells were fractionated as described in Materials and
Methods and analyzed by Western blotting using antibodies against
I B (C-20), I B (C-21), and amino-terminal I B (5432)
for the detection of the chimera protein. Samples from vector only,
HA-I B , I B  , or I B  N-NESmut are shown as
panels with arrows indicating I B , HA-I B , I B  or
I B  N-NESmut, respectively.
|
|
I
B
N-NES is sufficient to mediate postinduction export
function.
There are a total of three independent NES motifs
reported on I
B
-NF-
B complexes, the N- and C- terminal NES
motifs on I
B
and a p65 NES (2, 16, 17, 23, 40, 43).
There is a controversy as to which of these putative NES sequences
provide(s) the dominant nuclear export function for the complexes
during the postinduction phase. To conclusively determine whether N-NES is sufficient to dominantly export the NF-
B-I
B complexes in the
absence of C-NES, we asked whether I
B
N-terminal to the first
ankyrin repeat could support dominant nuclear export function in the
context of I
B
protein. We therefore generated an I
B
chimera
expression construct in which the I
B
N-terminal region upstream
of the first ankyrin repeat was swapped with the N-terminal aa 1 to 66 of I
B
(I
B

) and stably expressed it in
I
B
-deficient MEFs. Similar to HA-I
B
, the chimeric protein
was largely expressed in the cytoplasm (Fig. 6A, panel 1) and
associated with NF-
B as demonstrated by a coimmunoprecipitation
assay (not shown). Degradation of I
B

after pulse
stimulation with TNF-
was complete like I
B
but unlike I
B
(Fig. 6A, I
B

, panel 2; Fig. 6B, I
B

, lane 2).
Importantly, resynthesized I
B

was predominantly cytoplasmic, but LMB during the chase period trapped it in the nucleus
(Fig. 6A, I
B

, panels 3 and 4). These results suggest that
the N-terminal sequence of I
B
was able to dominantly export the
chimeric complexes out of the nucleus.
To formally demonstrate that the export function of I

B



is
mediated by the N-NES of I

B

, we mutated the NES sequence in
the
context of I

B



(I

B



N-NESmut), as described
previously
(
17). I

B



N-NESmut was also stably
introduced in the I

B
knockout MEFs. If N-NES is dominant for the
localization of NF-

B-I

B


complexes, then we expected
that the steady-state localization
of the complexes would be nuclear in
unstimulated cells. However,
if N-NES had a minor effect, the complexes
would be expected to
be predominantly cytoplasmic. Our
immunolocalization and biochemical
fractionation analyses demonstrated
that I

B



N-NESmut was predominantly
nuclear in unstimulated
cells (Fig.
6A, I

B



N-NESmut, panel
1; Fig.
6B,
I

B



N-NESmut, lane 5). The mutant protein was still
able to
associate with NF-

B in a co-immunoprecipitation assay
(not shown).
The nuclear I

B



N-NESmut was refractory to TNF

-induced
degradation (Fig.
6A, panel 2; Fig.
6B, lane 6), consistent with
the
hypothesis that NF-

B activation requires its cytoplasmic
localization. These findings demonstrate that N-NES of I

B

is
sufficient to confer export function that is dominant over any
known
NES sequences present on inactive NF-

B-I

B
complexes.
Postrepression activation of NF-

B also requires the I

B

N-NES.
Using a biochemical subfractionation assay, we also tested
whether the
postinduction-resynthesized I

B

, HA-I

B

, and I

B


proteins in the context of I

B

knockout cells were capable of
being degraded following a second stimulation with TNF-

(Fig.
6B).
Although resynthesized nuclear I

B

protein was refractory
to
restimulation with TNF-

, reconstituted HA-I

B

was capable
of
being degraded in response to a second TNF-

challenge (Fig.
6B,
I

B

, lanes 7 and 8; HA-I

B

, lanes 3 and 4). Moreover,
resynthesized
I

B



was also subjected to degradation
following restimulation
with TNF-

, demonstrating that the I

B

N-NES is sufficient to
confer export function on the I

B

protein
to mediate postrepression
activation of NF-

B (Fig.
6B,
I

B



, lanes 3 and
4).
 |
DISCUSSION |
Recently, several groups, including ours, discovered that
NF-
B-I
B
inactive complexes shuttle continuously between the
nuclear and cytoplasmic compartments to achieve a predominant
cytoplasmic localization during the absence of NF-
B-activating
signals (17, 23, 38, 43). Maintaining the cytoplasmic
localization of the inactive complexes is essential for NF-
B
function, since signals derived from either the plasma membrane or the
nucleus to target the degradation of I
B
are blocked if the
inactive complexes are sequestered in the nuclear compartment
(17, 18, 38). We therefore asked whether regulation of
NF-
B by nucleocytoplasmic shuttling was a conserved mechanism of all
I
B family members that negatively influence the important NF-
B
family of transcriptional regulators.
By scanning the primary amino acid sequences, we failed to identify a
similar N-NES motif present in I
B
in the N-terminal regions of
mammalian I
B
, p105/I
B
, p100, I
B
, Bcl-3, and the Drosophila I
B homolog cactus (Fig. 1A). A classical NES
sequence was also undetected in other regions of the I
B family
members. These observations suggested that I
B
might be the only
I
B family member that contained a novel nuclear export capacity to
mediate rapid export of nuclear NF-
B. These sequence analyses
further implied that I
B
might be a more recently evolved family
member. Coincidentally, I
B
is one of the major NF-
B target
genes in mammalian cells, which forms the autoinhibitory feedback loop to perform the postinduction repression of NF-
B function. Even without the presence of a conserved N-terminal NES on I
B
, we could not rule out the possibility that the NF-
B-I
B
complexes still shuttle in an LMB-sensitive manner, since a recent report has
shown that the p65 subunit of NF-
B possesses a bona fide NES motif
(16).
In the present study, we found that LMB selectively blocked the
signal-induced degradation of I
B
but not I
B
. I
B
knockout cells confirmed that TNF
-induced NF-
B activation cannot
be inhibited by LMB in the absence of I
B
, since
NF-
B-I
B
, and possibly other NF-
B-I
B complexes, is
insensitive to the LMB effect in these cells. Moreover, unlike
I
B
-containing NF-
B complexes, NF-
B-I
B
complexes that
contained the p65 subunit were still largely refractory to LMB-induced
nuclear accumulation. These surprising results enabled us to modify the
NF-
B cytoplasmic sequestration model (3, 12), in which
I
B proteins, excluding I
B
, are likely proficient in masking
the dual NF-
B NLS motifs. Studies with I
B

suggest that
the N-terminal sequence of I
B
is required for efficient masking
of NF-
B NLS sequences, since swapping of this region with that of
I
B
permitted NF-
B associated with the chimera protein to
shuttle between the cytoplasm and nucleus (Fig. 6 and unpublished observation).
The NF-
B-I
B
complexes, on the other hand, behave differently
from other I
B proteins in that cytoplasmic localization of the
complexes is a result of a dynamic balance between nuclear import and
active nuclear export forces. This notion is further supported by the
observation of incomplete p50 NLS masking by I
B
ankyrin repeats
in NF-
B-I
B
cocrystals (19, 22) and the finding
that the p65 NLS but not the p50 NLS motif is involved in direct
association with I
B
(36). Even though at least three NES motifs have been identified in the NF-
B-I
B
trimeric
complex (2, 16, 17, 23, 40, 43), our data demonstrate that their nucleocytoplasmic shuttling is dominantly controlled by the
I
B
N-NES motif, since (i) these complexes do not efficiently shuttle when the I
B
N-NES is mutated or deleted
(17), (ii) an I
B
C-NES mutation has little effect on
shuttling of the complexes (17, 23, 43), (iii) they also
efficiently shuttle without p65 protein or when p65-NES is deleted
(unpublished observation), and (iv) the I
B
N-NES is sufficient to
confer dominant shuttling function when grafted onto the I
B
protein.
What is unclear is whether there are any physiological advantages to
maintaining an energy-consuming and apparently futile shuttling process
in order to preserve the asymmetric distribution of NF-
B-I
B
complexes in the preinduced state. Perhaps it is more efficient to
regulate the localization of shuttling proteins by simply adjusting the
rate of nuclear entry versus export in order to drastically alter the
steady-state subcellular distribution of the complexes. It is
conceivable that as yet undiscovered physiological control of NF-
B
activity may exist which involves the altered regulation of
nucleocytoplasmic shuttling of the inactive complexes. Adjusting the
kinetics of shuttling by having the rate of import exceed the rate of
export may be a novel mechanism to attenuate NF-
B function. However,
our findings suggest that, depending on the ratio of NF-
B associated
with I
B
or I
B
or other I
B family members, only a subset
of inactive NF-
B pools may be subjected to this type of regulation.
This may explain why certain investigators fail to observe large
effects of LMB on NF-
B activation in different experimental settings
(23).
In contrast, what is clear from our present study is that the nuclear
export function of I
B
N-NES is essential for rapid and efficient
export of inactive NF-
B complexes out of the nucleus during the
postinduction phase. Our findings from I
B
knockout cells
demonstrate that other I
B family members could not efficiently perform this function. We found, in accordance with studies using cells
isolated from I
B
knockin mice (6), newly synthesized I
B
protein was able to enter the nucleus and repress NF-
B
DNA-binding activity. However, I
B
, which does not possess a
functional NES, could not efficiently carry NF-
B out of the nucleus.
Thus, only I
B
protein was able to prime the NF-
B system for a
subsequent reactivation event or provide a permissive condition for
postrepression activation to take place.
Wild-type cells, which can properly export postinduced nuclear NF-
B
out to the cytoplasm, could efficiently respond to secondary NF-
B
stimuli. I
B
-deficient cells, however, were refractory to this
NF-
B reactivation process. Thus, it is logical to consider that the
initial postinduction repression of NF-
B DNA-binding activity is an
important mechanism to rapidly shut off NF-
B-dependent gene
transcription following a short exposure to cytokine stimulation in a
biological setting. This I
B-mediated repression and removal of
NF-
B from its DNA-binding sites may be necessary, since NF-
B has
been shown to bind its cognate sites with very slow off rates in vitro
(36). In addition, efficient removal of NF-
B from cognate DNA-binding sites may also be critical for allowing the NF-
B-I
B
complexes to interact with the soluble transport
machinery, Crm1 and RanGTP (25, 28). Subsequently, the
nuclear export of inactive NF-
B-I
B
complexes provides another
important function to allow cells to become quickly permissive for a
second challenge with either cytokine, bacterial, or viral insults.
Without efficient export of nuclear NF-
B, the secondary activation
process is defective. Thus, the nuclear export function of I
B
may
contribute to the ability of an organism to respond rapidly to multiple
cellular infections.
It is interesting to consider whether the N-NES of I
B
may have
evolved to permit sequential NF-
B activation. Because the N-NES of
I
B
needs to interact with Crm1 for export function, i.e., exposed
on the surface of NF-
B-I
B
complexes, this domain may have
lost the capacity to efficiently mask the p50 NLS. These events may
have caused the NF-
B-I
B
complexes to nucleocytoplasmically shuttle in the preinduced conditions by default. Important goals of
future investigation include determining how nucleocytoplasmic shuttling of NF-
B-I
B
complexes is regulated and whether
disruption of these regulatory mechanisms has drastic biological and/or
pathological consequences.
It is well known that I
B
is less responsive to stimulus-induced
degradation than I
B
, as determined by Western blot analyses. However, the mechanism for this resistance is unclear. Unexpectedly, we
found that when I
B
degradation was assessed by immunostaining using C20 I
B
antibody, TNF-
stimulation caused almost complete loss of immunoreactivity, similar to that found with I
B
antibodies (Fig. 6). However, the same I
B
antibody still showed
only partial degradation on Western blot analyses, consistent with the
weaker responsiveness of I
B
to TNF-
-induced degradation. The
pool of I
B
that was resistant to initial TNF-
stimulation
remained refractory to secondary stimulation even though it remained
cytoplasmic, indicating that this pool of I
B
is not accessible to
the stimulus-induced degradation pathway. A recent study by Ghosh and
colleagues found that
B-Ras might be critical for retarding I
B
degradation during the NF-
B activation process (9).
Interestingly, the interaction between
B-Ras and I
B
is
mediated by the C-terminal region of I
B
, which contains the
epitope recognized by C20 antibody. It is possible that when
B-Ras
is bound to I
B
, C20 may not recognize I
B
due to epitope
masking. Thus, it is tempting to speculate that there are at least two
pools of I
B
, one free of
B-Ras and the other associated with
it. The I
B
pool that is free of
B-Ras may be accessible for
immunostaining with C20 and efficiently degraded by TNF-
stimulation. In contrast, I
B
bound to
B-Ras might be
inaccessible for immunostaining using C20 antibody and resistant to
degradation. Thus, our study suggests that the C20 antibody may provide
a useful tool to help elucidate the mechanism of partial degradation of
I
B
during NF-
B activation processes.
 |
ACKNOWLEDGMENTS |
We thank D. Baltimore for I
B
knockout MEFs and p65 knockout
3T3 cells, D. Ballard for human p65 cDNA, S. Shumway for critical reading of the manuscript, and M. Yoshida for continued support and the
generous gift of LMB.
This work was supported by an NIH predoctoral training grant award
through the Molecular and Cellular Pharmacology graduate program to
T.T.H. and NIH RO1 CA77474, a Howard Hughes Medical Institute fund
through the University of Wisconsin Medical School, and the Shaw
Scientist Award from the Milwaukee Foundation to S.M.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Pharmacology, University of Wisconsin
Madison, 3795 Medical Sciences Center, 1300 University Avenue, Madison, WI 53706-1532. Phone: (608) 262-9281. Fax: (608) 262-1257. E-mail:
smiyamot{at}facstaff.wisc.edu.
 |
REFERENCES |
| 1.
|
Arenzana-Seisdedos, F.,
J. Thompson,
M. S. Rodriguez,
F. Bachelerie,
D. Thomas, and R. T. Hay.
1995.
Inducible nuclear expression of newly synthesized I B negatively regulates DNA-binding and transcriptional activities of NF- B.
Mol. Cell. Biol.
15:2689-2696[Abstract].
|
| 2.
|
Arenzana-Seisdedos, F.,
T. Turpin,
M. Rodriguez,
D. Thomas,
R. T. Hay,
J.-L. Virelizier, and C. Dargemont.
1997.
Nuclear localization of I B promotes active transport of NF- B from the nucleus to the cytoplasm.
J. Cell Sci.
110:369-378[Abstract].
|
| 3.
|
Beg, A. A.,
S. M. Ruben,
R. I. Scheinman,
S. Haskill,
C. A. Rosen, and A. S. J. Baldwin.
1992.
I B interacts with the nuclear localization sequences of the subunits of NF- B: a mechanism for cytoplasmic retention.
Genes Dev.
6:1899-1913[Abstract/Free Full Text].
|
| 4.
|
Beg, A. A.,
W. C. Sha,
R. T. Bronson,
S. Ghosh, and D. Baltimore.
1995.
Embryonic lethality and liver degeneration in mice lacking the RelA component of NF- B.
Nature
376:167-70[CrossRef][Medline].
|
| 5.
|
Cao, Z. D.,
J. Xiong,
M. Takeuchi,
T. Kurama, and D. V. Goeddel.
1996.
TRAF6 is a signal transducer for interleukin-1.
Nature
383:443-446[CrossRef][Medline].
|
| 6.
|
Cheng, J. D.,
R. P. Ryseck,
R. M. Attar,
D. Dambach, and R. Bravo.
1998.
Functional redundancy of the nuclear factor B inhibitors I B and I B .
J. Exp. Med.
188:1055-1062[Abstract/Free Full Text].
|
| 7.
|
Cheng, Q.,
C. A. Cant,
T. Moll,
R. Hofer-Warbinek,
E. Wagner,
M. L. Birnstiel,
F. H. Bach, and R. de Martin.
1994.
NF- B subunit-specific regulation of the I B promoter.
J. Biol. Chem.
269:13551-13557[Abstract/Free Full Text].
|
| 8.
|
Chiao, P. J.,
S. Miyamoto, and I. M. Verma.
1994.
Autoregulation of I B activity.
Proc. Natl. Acad. Sci. USA
91:28-32[Abstract/Free Full Text].
|
| 9.
|
Fenwick, C.,
S.-Y. Na,
R. E. Voll,
H. Zhong,
S.-Y. Im,
J. W. Lee, and S. Ghosh.
2000.
A subclass of ras proteins that regulate the degradation of I B.
Science
287:869-873[Abstract/Free Full Text].
|
| 10.
|
Fornerod, M.,
M. Ohno,
M. Yoshida, and I. W. Mattaj.
1997.
CRM1 is an export receptor for leucine-rich nuclear export signals.
Cell
90:1051-1060[CrossRef][Medline].
|
| 11.
|
Fukuda, M.,
S. Asano,
T. Nakamura,
M. Adachi,
M. Yoshida,
M. Yanagida, and N. E..
1997.
CRM1 is responsible for intracellular transport mediated by the nuclear export signal.
Nature
390:308-311[CrossRef][Medline].
|
| 12.
|
Ganchi, P. A.,
S. C. Sun,
W. C. Greene, and D. W. Ballard.
1992.
I B/MAD-3 masks the nuclear localization signal of NF- B p65 and requires the transactivation domain to inhibit NF- B p65 DNA binding.
Mol. Biol. Cell
3:1339-1352[Abstract].
|
| 13.
|
Geisler, R.,
A. Bergmann,
Y. Hiromi, and C. Nusslein-Volhard.
1992.
cactus, a gene involved in dorsoventral pattern formation of Drosophila, is related to the I B gene family of vertebrates.
Cell
71:613-621[CrossRef][Medline].
|
| 14.
|
Ghosh, S.,
A. M. Gifford,
L. R. Riviere,
P. Tempst,
G. P. Nolan, and D. Baltimore.
1990.
Cloning of the p50 DNA binding subunit of NF- B: homology to rel and dorsal.
Cell
62:1019-1029[CrossRef][Medline].
|
| 15.
|
Ghosh, S.,
M. J. May, and E. B. Kopp.
1998.
NF- B and rel proteins: evolutionarily conserved mediators of immune responses.
Annu. Rev. Immunol.
16:225-260[CrossRef][Medline].
|
| 16.
|
Harhaj, E. W., and S. C. Sun.
1999.
Regulation of RelA subcellular localization by a putative nuclear export signal and p50.
Mol. Cell. Biol.
19:7088-7095[Abstract/Free Full Text].
|
| 17.
|
Huang, T. T.,
N. Kudo,
M. Yoshida, and S. Miyamoto.
2000.
A nuclear export signal in the N-terminal regulatory domain of I B controls cytoplasmic localization of inactive NF- B/I B complexes.
Proc. Natl. Acad. Sci. USA
97:1014-1019[Abstract/Free Full Text].
|
| 18.
|
Huang, T. T.,
S. M. Wuerzberger-Davis,
B. J. Seufzer,
S. D. Shumway,
T. Kurama,
D. A. Boothman, and S. Miyamoto.
2000.
NF- B activation by camptothecin: a linkage between nuclear DNA damage and cytoplasmic signaling events.
J. Biol. Chem.
275:9501-9509[Abstract/Free Full Text].
|
| 19.
|
Huxford, T.,
D.-B. Huang,
S. Malek, and G. Ghosh.
1998.
The crystal structure of the I Ba/NF- B complex reveals mechanisms of NF- B inactivation.
Cell
95:759-770[CrossRef][Medline].
|
| 20.
|
Inoue, J.,
L. D. Kerr,
A. Kakizuka, and I. M. Verma.
1992.
I B , a 70 kd protein identical to the C-terminal half of p110 NF- B: a new member of the I B family.
Cell
68:1109-1120[CrossRef][Medline].
|
| 21.
|
Ito, C. Y.,
A. G. Kazantsev, and A. S. J. Baldwin.
1994.
Three NF- B sites in the I B promoter are required for induction of gene expression by TNF .
Nucleic Acids Res.
22:3787-3792[Abstract/Free Full Text].
|
| 22.
|
Jacobs, M. D., and S. C. Harrison.
1998.
Structure of an I B /NF- B complex.
Cell
95:749-758[CrossRef][Medline].
|
| 23.
|
Johnson, C.,
D. V. Antwerp, and T. J. Hope.
1999.
An N-terminal nuclear export signal is required for the nucleocytoplasmic shuttling of I B .
EMBO J.
18:6682-6693[CrossRef][Medline].
|
| 24.
|
Kaffman, A., and E. K. O'Shea.
1999.
Regulation of nuclear localization: a key to a door.
Annu. Rev. Cell Dev. Biol.
15:291-339[CrossRef][Medline].
|
| 25.
|
Kudo, N.,
N. Matsumori,
H. Taoka,
D. Fujiwara,
E. P. Schreiner,
B. Wolff,
M. Yoshida, and S. Horinouchi.
1999.
Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region.
Proc. Natl. Acad. Sci. USA
96:9112-9117[Abstract/Free Full Text].
|
| 26.
|
Kudo, N.,
B. Wolff,
T. Sekimoto,
E. P. Schreiner,
Y. Yoneda,
M. Yanagida,
S. Horinouchi, and M. Yoshida.
1998.
Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1.
Exp. Cell Res.
242:540-547[CrossRef][Medline].
|
| 27.
|
Le Bail, O.,
R. Schmidt-Ullrich, and A. Israel.
1993.
Promoter analysis of the gene encoding the I B /MAD3 inhibitor of NF- B: positive regulation by members of the rel/NF- B family.
EMBO J.
12:5043-5049[Medline].
|
| 28.
|
Mattaj, I. W., and L. Englmeier.
1998.
Nucleocytoplasmic transport: the soluble phase.
Annu. Rev. Biochem.
67:265-306[CrossRef][Medline].
|
| 29.
|
Mercurio, F.,
J. A. DiDonato,
C. Rosette, and M. Karin.
1993.
p105 and p98 precursor proteins play an active role in NF- B-mediated signal transduction.
Genes Dev.
7:705-718[Abstract/Free Full Text].
|
| 30.
|
Miyamoto, S.,
P. J. Chiao, and I. M. Verma.
1994.
Enhanced I B degradation is responsible for constitutive NF- B activity in mature murine B-cell lines.
Mol. Cell. Biol.
14:3276-3282[Abstract/Free Full Text].
|
| 31.
|
Miyamoto, S.,
B. Seufzer, and S. Shumway.
1998.
Novel I B degradation process in WEHI231 murine immature B cells.
Mol. Cell. Biol.
18:19-29[Abstract/Free Full Text].
|
| 32.
|
Naviaux, R. K.,
E. Costanzi,
M. Hass, and I. M. Verma.
1996.
The pCL vector system rapid production of helper-free, high-titer, recombinant retroviruses.
J. Virol.
70:5701-5705[Abstract/Free Full Text].
|
| 33.
|
Neri, A.,
C. C. Chang,
L. Lombardi,
M. Salina,
P. Corradini,
A. T. Maiolo,
R. S. Chaganti, and R. Dalla-Favera.
1991.
B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF- B p50.
Cell
67:1075-1087[CrossRef][Medline].
|
| 34.
|
Ohno, H.,
G. Takimoto, and T. W. McKeithan.
1990.
The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control.
Cell
60:991-997[CrossRef][Medline].
|
| 35.
|
Ossareh-Nazari, B.,
F. Bachelerie, and C. Dargemont.
1997.
Evidence for a role of CRM1 in signal-mediated nuclear protein export.
Science
278:141-144[Abstract/Free Full Text].
|
| 36.
|
Phelps, C. B.,
L. L. Sengchanthalangsy,
T. Huxford, and G. Ghosh.
2000.
Mechanisms of I B binding to NF- B dimers.
J. Biol. Chem.
275:29840-29846[Abstract/Free Full Text].
|
| 37.
|
Rice, N. R.,
M. L. MacKichan, and A. Israel.
1992.
The precursor of NF- B p50 has I B-like functions.
Cell
71:243-253[CrossRef][Medline].
|
| 38.
|
Rodriguez, M. S.,
J. Thompson,
R. T. Hay, and C. Dargemont.
1999.
Nuclear retention of I B protects it from signal-induced degradation and inhibits nuclear factor B transcriptional activation.
J. Biol. Chem.
274:9108-9115[Abstract/Free Full Text].
|
| 39.
|
Sachdev, S.,
S. Bagchi,
D. D. Zhang,
A. C. Mings, and M. Hannink.
2000.
Nuclear import of I B is accomplished by a ran-independent transport pathway.
Mol. Cell. Biol.
20:1571-1582[Abstract/Free Full Text].
|
| 40.
|
Sachdev, S., and M. Hannink.
1998.
Loss of I B -mediated control over nuclear import and DNA binding enables oncogenic activation of c-Rel.
Mol. Cell. Biol.
18:5445-5456[Abstract/Free Full Text].
|
| 41.
|
Stade, K.,
C. S. Ford,
C. Guthrie, and K. Weis.
1997.
Exportin 1 (Crm1p) is an essential nuclear export factor.
Cell
90:1041-1050[CrossRef][Medline].
|
| 42.
|
Sun, S. C.,
P. A. Ganchi,
D. W. Ballard, and W. C. Greene.
1993.
NF- B controls expression of inhibitor I B : evidence for an inducible autoregulatory pathway.
Science
259:1912-1915[Abstract/Free Full Text].
|
| 43.
|
Tam, W. F.,
L. H. Lee,
L. Davis, and R. Sen.
2000.
Cytoplasmic sequestration of rel proteins by I B requires Crm1-dependent nuclear export.
Mol. Cell. Biol.
20:2269-2284[Abstract/Free Full Text].
|
| 44.
|
Thompson, J. E.,
R. J. Phillips,
H. Erdjument-Bromage,
P. Tempst, and S. Ghosh.
1995.
I B regulates the persistent response in a biphasic activation of NF- B.
Cell
80:573-582[CrossRef][Medline].
|
| 45.
|
Verma, I. M.,
J. K. Stevenson,
E. M. Schwarz,
D. Van Antwerp, and S. Miyamoto.
1995.
Rel/NF- B/I B family: intimate tales of association and dissociation.
Genes Dev.
9:2723-2735[Free Full Text].
|
| 46.
|
Whiteside, S. T.,
J.-C. Epinat,
N. R. Rice, and A. Israel.
1997.
I B , a novel member of the I B family, controls RelA and cRel NF- B activity.
EMBO J.
16:1413-1426[CrossRef][Medline].
|
| 47.
|
Zabel, U., and P. A. Baeuerle.
1990.
Purified human I B can rapidly dissociate the complex of the NF- B transcription factor with its cognate DNA.
Cell
61:255-265[CrossRef][Medline].
|
Molecular and Cellular Biology, July 2001, p. 4737-4747, Vol. 21, No. 14
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.14.4737-4747.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Liberatore, R. A., Goff, S. P., Nunes, I.
(2009). NF-{kappa}B activity is constitutively elevated in c-Abl null fibroblasts. Proc. Natl. Acad. Sci. USA
106: 17823-17828
[Abstract]
[Full Text]
-
Ghafoori, P., Yoshimura, T., Turpie, B., Masli, S.
(2009). Increased I{kappa}B{alpha} expression is essential for the tolerogenic property of TGF-{beta}-exposed APCs. FASEB J.
23: 2226-2234
[Abstract]
[Full Text]
-
Lindstrom, T. M., Mohan, A. R., Johnson, M. R., Bennett, P. R.
(2008). Histone Deacetylase Inhibitors Exert Time-Dependent Effects on Nuclear Factor-{kappa}B but Consistently Suppress the Expression of Proinflammatory Genes in Human Myometrial Cells. Mol. Pharmacol.
74: 109-121
[Abstract]
[Full Text]
-
Williams, J. L., Ji, P., Ouyang, N., Liu, X., Rigas, B.
(2008). NO-donating aspirin inhibits the activation of NF-{kappa}B in human cancer cell lines and Min mice. Carcinogenesis
29: 390-397
[Abstract]
[Full Text]
-
Qu, J., Liu, G.-H., Huang, B., Chen, C.
(2007). Nitric oxide controls nuclear export of APE1/Ref-1 through S-nitrosation of Cysteines 93 and 310. Nucleic Acids Res
35: 2522-2532
[Abstract]
[Full Text]
-
Silk, R. N., Bowick, G. C., Abrams, C. C., Dixon, L. K.
(2007). African swine fever virus A238L inhibitor of NF-{kappa}B and of calcineurin phosphatase is imported actively into the nucleus and exported by a CRM1-mediated pathway. J. Gen. Virol.
88: 411-419
[Abstract]
[Full Text]
-
Berchtold, C. M., Wu, Z.-H., Huang, T. T., Miyamoto, S.
(2007). Calcium-Dependent Regulation of NEMO Nuclear Export in Response to Genotoxic Stimuli. Mol. Cell. Biol.
27: 497-509
[Abstract]
[Full Text]
-
Aguilera, C., Fernandez-Majada, V., Ingles-Esteve, J., Rodilla, V., Bigas, A., Espinosa, L.
(2006). Efficient nuclear export of p65-I{kappa}B{alpha} complexes requires 14-3-3 proteins.. J. Cell Sci.
119: 3695-3704
[Abstract]
[Full Text]
-
Ganesh, L., Yoshimoto, T., Moorthy, N. C., Akahata, W., Boehm, M., Nabel, E. G., Nabel, G. J.
(2006). Protein Methyltransferase 2 Inhibits NF-{kappa}B Function and Promotes Apoptosis. Mol. Cell. Biol.
26: 3864-3874
[Abstract]
[Full Text]
-
Kang, B.-N., Tirumurugaan, K. G., Deshpande, D. A., Amrani, Y., Panettieri, R. A., Walseth, T. F., Kannan, M. S.
(2006). Transcriptional regulation of CD38 expression by tumor necrosis factor-{alpha} in human airway smooth muscle cells: role of NF-{kappa}B and sensitivity to glucocorticoids. FASEB J.
20: 1000-1002
[Abstract]
[Full Text]
-
Xiong, Y., Kotake, Y.
(2006). No exit strategy? No problem: APC inhibits beta-catenin inside the nucleus.. Genes Dev.
20: 637-642
[Full Text]
-
Mittal, A., Papa, S., Franzoso, G., Sen, R.
(2006). NF-{kappa}B-Dependent Regulation of the Timing of Activation-Induced Cell Death of T Lymphocytes. J. Immunol.
176: 2183-2189
[Abstract]
[Full Text]
-
Lindstrom, T. M, Bennett, P. R
(2005). The role of nuclear factor kappa B in human labour. Reproduction
130: 569-581
[Abstract]
[Full Text]
-
Wuerzberger-Davis, S. M., Chang, P.-Y., Berchtold, C., Miyamoto, S.
(2005). Enhanced G2-M Arrest by Nuclear Factor-{kappa}B-Dependent p21waf1/cip1 Induction. Mol Cancer Res
3: 345-353
[Abstract]
[Full Text]
-
O'Connor, S., Shumway, S., Miyamoto, S.
(2005). Inhibition of I{kappa}B{alpha} Nuclear Export as an Approach to Abrogate Nuclear Factor-{kappa}B-Dependent Cancer Cell Survival. Mol Cancer Res
3: 42-49
[Abstract]
[Full Text]
-
Lahav, G.
(2004). The Strength of Indecisiveness: Oscillatory Behavior for Better Cell Fate Determination. Sci Signal
2004: pe55-pe55
[Abstract]
[Full Text]
-
Aguilera, C., Hoya-Arias, R., Haegeman, G., Espinosa, L., Bigas, A.
(2004). Recruitment of I{kappa}B{alpha} to the hes1 promoter is associated with transcriptional repression. Proc. Natl. Acad. Sci. USA
101: 16537-16542
[Abstract]
[Full Text]
-
Verma, I M
(2004). Nuclear factor (NF)-{kappa}B proteins: therapeutic targets. Ann Rheum Dis
63: ii57-ii61
[Full Text]
-
Ajenjo, N., Canon, E., Sanchez-Perez, I., Matallanas, D., Leon, J., Perona, R., Crespo, P.
(2004). Subcellular Localization Determines the Protective Effects of Activated ERK2 against Distinct Apoptogenic Stimuli in Myeloid Leukemia Cells. J. Biol. Chem.
279: 32813-32823
[Abstract]
[Full Text]
-
Takahashi, S., McConnell, M. J., Harigae, H., Kaku, M., Sasaki, T., Melnick, A. M., Licht, J. D.
(2004). The Flt3 internal tandem duplication mutant inhibits the function of transcriptional repressors by blocking interactions with SMRT. Blood
103: 4650-4658
[Abstract]
[Full Text]
-
Viatour, P., Legrand-Poels, S., van Lint, C., Warnier, M., Merville, M.-P., Gielen, J., Piette, J., Bours, V., Chariot, A.
(2003). Cytoplasmic I{kappa}B{alpha} Increases NF-{kappa}B-independent Transcription through Binding to Histone Deacetylase (HDAC) 1 and HDAC3. J. Biol. Chem.
278: 46541-46548
[Abstract]
[Full Text]
-
Xia, J., Lee, D. H., Taylor, J., Vandelft, M., Truant, R.
(2003). Huntingtin contains a highly conserved nuclear export signal. Hum Mol Genet
12: 1393-1403
[Abstract]
[Full Text]
-
Malek, S., Huang, D.-B., Huxford, T., Ghosh, S., Ghosh, G.
(2003). X-ray Crystal Structure of an I{kappa}B{beta}{middle dot}NF-{kappa}B p65 Homodimer Complex. J. Biol. Chem.
278: 23094-23100
[Abstract]
[Full Text]
-
Chen, Y., Wu, J., Ghosh, G.
(2003). {kappa}B-Ras Binds to the Unique Insert within the Ankyrin Repeat Domain of I{kappa}B{beta} and Regulates Cytoplasmic Retention of I{kappa}B{beta}{middle dot}NF-{kappa}B Complexes. J. Biol. Chem.
278: 23101-23106
[Abstract]
[Full Text]
-
Espinosa, L., Ingles-Esteve, J., Robert-Moreno, A., Bigas, A.
(2003). Ikappa Balpha and p65 Regulate the Cytoplasmic Shuttling of Nuclear Corepressors: Cross-talk between Notch and NFkappa B Pathways. Mol. Biol. Cell
14: 491-502
[Abstract]
[Full Text]
-
Mizgerd, J. P., Scott, M. L., Spieker, M. R., Doerschuk, C. M.
(2002). Functions of I{kappa}B Proteins in Inflammatory Responses to Escherichia coli LPS in Mouse Lungs. Am. J. Respir. Cell Mol. Bio.
27: 575-582
[Abstract]
[Full Text]
-
Kawai, H., Nie, L., Yuan, Z.-M.
(2002). Inactivation of NF-{kappa}B-Dependent Cell Survival, a Novel Mechanism for the Proapoptotic Function of c-Abl. Mol. Cell. Biol.
22: 6079-6088
[Abstract]
[Full Text]
-
Huang, T. T., Feinberg, S. L., Suryanarayanan, S., Miyamoto, S.
(2002). The Zinc Finger Domain of NEMO Is Selectively Required for NF-{kappa}B Activation by UV Radiation and Topoisomerase Inhibitors. Mol. Cell. Biol.
22: 5813-5825
[Abstract]
[Full Text]
-
Lee, S.-H., Hannink, M.
(2002). Characterization of the Nuclear Import and Export Functions of Ikappa Bepsilon. J. Biol. Chem.
277: 23358-23366
[Abstract]
[Full Text]
-
Brivanlou, A. H., Darnell, J. E. Jr.
(2002). Signal Transduction and the Control of Gene Expression. Science
295: 813-818
[Abstract]
[Full Text]